Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UF scientists say stem cells may trigger bone cancer

23.11.2005


Stem cells may cause some forms of bone cancer, University of Florida scientists report.



The researchers are the first to identify a population of cells with characteristics of adult and embryonic stem cells in cultures derived from biopsies of patients’ bone tumors. They describe their findings in this month’s issue of the medical journal Neoplasia.

"We’re saying the cell of origin of these tumors may be very, very primitive," said C. Parker Gibbs, M.D., an associate professor of orthopaedic oncology and a member of the UF Shands Cancer Center. Gibbs collaborated with several UF scientists, including Dennis A. Steindler, Ph.D., director of UF’s McKnight Brain Institute.


Researchers elsewhere already have implicated stem cells in the development of leukemia, and Steindler’s lab previously discovered stem-like cells in brain cancer. Others have identified these same cells in some breast cancers.

The studies are laying the foundation for novel ideas about cancer and its development, and are opening new avenues of research that could someday lead to more effective treatments that target the mutant cells that grow into tumors.

The cancer stem cell theory holds that a small subpopulation of rogue stem cells exists within a tumor and has the ability to sustain itself. As these abnormal cells divide, they may generate the bulk of a malignant tumor, then help to spur on its growth.

"Most current chemotherapeutic regimens are developed against the bulk tumor and therefore may not affect the small number of malignant stem cells, allowing recurrence and even metastasis," Gibbs said.

Osteosarcoma is the most common bone malignancy in children, most of whom are 10 to 20 years old and in a period of rapid growth when the disease is diagnosed. Despite advances in surgery and chemotherapy, many patients do not survive long-term.

"Osteosarcoma is an extremely aggressive tumor that destroys bone and requires surgery and chemotherapy to cure," Gibbs said. "The current cure rate is approximately 65 percent with yearlong chemotherapy and radical surgery, but we still lose 30 to 40 percent of these kids despite that kind of aggressive therapy. So the thought was, ’Gee, what are we missing?’

"The existence of stem-like cells in bone sarcomas suggests that the study of stem cell biology may provide opportunities for targeted therapies that are markedly less toxic than current aggressive chemotherapy and surgical protocols," he added.

Stem cells are primed to multiply and divide in almost unlimited fashion, and develop into many kinds of organs. A bone stem cell, for example, develops into bone. Osteosarcoma resembles bone but looks abnormal. A stem cell "gone bad" could potentially multiply to produce an abnormal organ that is cancerous, Gibbs said.

"Osteosarcoma occurs right next to the most active centers of growth, the growth plates in long bones," Gibbs said. "These areas of the skeleton contain many stem cells undergoing rapid growth and developing into bone during the adolescent growth spurt. It makes sense that bone sarcomas occur in anatomic areas containing stimulated stem cells. A stimulated, abnormal stem cell might therefore be the cell of origin of osteosarcoma."

UF researchers studied two types of tumors - osteosarcomas common in childhood and adolescence, and chondrosarcomas, a form of adult bone cancer that requires aggressive surgery to treat because it does not respond to chemotherapy or radiation.

Using specialized cell culture techniques, they were able to isolate stem-like cells from bone tumors. About one in 1,000 cells in the samples they studied had features of embryonic stem cells. The researchers also found abundant levels in their samples of the two key factors that help maintain embryonic stem cells in a very primitive state.

"We found expression of these two transcription factors not only in culture but also in actual tumors," Gibbs said. "We were first to show these cancers expressed both of these embryonic stem cell markers.

"That these cells exist in bone sarcomas suggests osteosarcomas and chondrosarcomas might be stem cell diseases," he added. "This is pretty exciting stuff."

The discovery gives scientists new targets for treatment, he said.

"The next step, which is ongoing, is isolating and growing tumors from these cells in animals and then finding ways to interfere with that growth based on their stem cell biology," Gibbs said. "So the study of embryonic and adult stem cell biology may provide more effective ways to treat childhood sarcomas."

Still, the precise role stem-like cells play in the development of cancer is not entirely clear, said Eric C. Holland, M.D., Ph.D., an associate professor in the departments of neurosurgery, neurology, and cancer biology and genetics at Memorial Sloan-Kettering Cancer Center.

"Dr. Gibbs’ identification of very early cells in these tumors has important implications for our understanding of cancer biology," Holland said. "But further work needs to be done to determine what the role of cells of this nature is in cancer biology - whether they are the cells of origin, the cause of cancer or the effect of the environment generated by a tumor. Clearly it’s quite an exciting time for people who are interested in cells like this."

Melanie Ross | EurekAlert!
Further information:
http://www.ufl.edu

More articles from Life Sciences:

nachricht New insights into the world of trypanosomes
23.08.2017 | Julius-Maximilians-Universität Würzburg

nachricht New Test for Rare Immunodeficiency
23.08.2017 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>